Bio View (Israel) Buy Hold or Sell Recommendation
| BIOV Stock | ILS 27.90 0.10 0.36% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Bio View is 'Sell'. Macroaxis provides Bio View buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bio View positions. The advice algorithm takes into account all of Bio View's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Bio View's buy or sell advice are summarized below:
Real Value 23.72 | Hype Value 27.9 | Market Value 27.9 | Naive Value 26.23 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bio View given historical horizon and risk tolerance towards Bio View. When Macroaxis issues a 'buy' or 'sell' recommendation for Bio View, the advice is generated through an automated system that utilizes algorithms and statistical models.
Bio |
Execute Bio View Buy or Sell Advice
The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio View. Macroaxis does not own or have any residual interests in Bio View or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio View's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Bio View Trading Alerts and Improvement Suggestions
| Bio View generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are held by company insiders |
Bio View Returns Distribution Density
The distribution of Bio View's historical returns is an attempt to chart the uncertainty of Bio View's future price movements. The chart of the probability distribution of Bio View daily returns describes the distribution of returns around its average expected value. We use Bio View price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio View returns is essential to provide solid investment advice for Bio View.
| Mean Return | -0.13 | Value At Risk | -4.17 | Potential Upside | 4.47 | Standard Deviation | 2.85 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio View historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bio View Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio View or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio View's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.17 | |
β | Beta against NYSE Composite | 0.40 | |
σ | Overall volatility | 2.29 | |
Ir | Information ratio | -0.08 |
Bio View Volatility Alert
Bio View exhibits very low volatility with skewness of 0.33 and kurtosis of 2.32. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio View's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio View's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bio View Fundamentals Vs Peers
Comparing Bio View's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio View's direct or indirect competition across all of the common fundamentals between Bio View and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio View or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio View's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio View by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bio View to competition |
| Fundamentals | Bio View | Peer Average |
| Return On Equity | 0.0399 | -0.31 |
| Return On Asset | 0.0091 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 35.4 M | 16.62 B |
| Shares Outstanding | 13.75 M | 571.82 M |
| Shares Owned By Insiders | 51.58 % | 10.09 % |
| Price To Book | 1.72 X | 9.51 X |
| Price To Sales | 1.71 X | 11.42 X |
| Revenue | 30.51 M | 9.43 B |
| Gross Profit | 17.59 M | 27.38 B |
| EBITDA | 4.72 M | 3.9 B |
| Net Income | 2.18 M | 570.98 M |
| Cash And Equivalents | 17.67 M | 2.7 B |
| Cash Per Share | 1.24 X | 5.01 X |
| Total Debt | 2.57 M | 5.32 B |
| Debt To Equity | 11.80 % | 48.70 % |
| Current Ratio | 2.14 X | 2.16 X |
| Book Value Per Share | 2.00 X | 1.93 K |
| Cash Flow From Operations | 3.25 M | 971.22 M |
| Earnings Per Share | 0.09 X | 3.12 X |
| Number Of Employees | 35 | 18.84 K |
| Beta | 0.53 | -0.15 |
| Market Capitalization | 53.86 M | 19.03 B |
| Total Asset | 40.02 M | 29.47 B |
| Retained Earnings | (29 M) | 9.33 B |
| Working Capital | 18 M | 1.48 B |
| Current Asset | 26 M | 9.34 B |
| Current Liabilities | 8 M | 7.9 B |
| Z Score | 12.0 | 8.72 |
| Net Asset | 40.02 M |
Bio View Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bio View Buy or Sell Advice
When is the right time to buy or sell Bio View? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bio View in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumption Thematic Idea Now
Consumption
Companies that deliver final goods such as cars or clothing for consumption by consumers. The Consumption theme has 18 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumption Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio View Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |